Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.080
0.00 (0.00%)
Jul 27, 2026, 3:43 PM CET
Arterra Bioscience Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.12 | 5.27 | 4.95 | 5.3 | 4.61 | |
Revenue Growth | 16.12% | 6.37% | -6.65% | 15.09% | 6.95% |
Cost of Revenue | 1.89 | 1.79 | 1.72 | 1.65 | 1.3 |
Gross Profit | 4.22 | 3.47 | 3.23 | 3.66 | 3.3 |
Selling, General & Admin | 1.94 | 1.69 | 1.56 | 1.47 | 1.39 |
Depreciation & Amortization Expenses | 0.29 | 0.34 | 0.53 | 0.53 | 0.49 |
Other Operating Expenses | 0.06 | 0.07 | 0.08 | 0.05 | 0.18 |
Total Operating Expenses | 2.29 | 2.1 | 2.17 | 2.06 | 2.06 |
Operating Income | 1.93 | 1.37 | 1.06 | 1.6 | 1.25 |
Interest Income | 0.26 | 0.46 | 0.09 | 0.21 | 0.07 |
Interest Expense | -0 | -0 | -0.02 | -0.02 | -0.02 |
Other Non-Operating Income (Expense) | -0.13 | - | - | - | - |
Total Non-Operating Income (Expense) | 0.12 | 0.46 | 0.07 | 0.19 | 0.05 |
Pretax Income | 2 | 1.7 | 1.3 | 1.8 | 1.27 |
Provision for Income Taxes | -0.01 | 0.36 | 0.23 | 0.38 | 0.16 |
Net Income | 2.01 | 1.34 | 1.08 | 1.41 | 1.11 |
Net Income to Common | 2.01 | 1.34 | 1.08 | 1.41 | 1.11 |
Net Income Growth | 50.09% | 24.21% | -23.89% | 27.33% | 0.18% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 |
Shares Change | - | - | - | - | 1.74% |
EPS (Basic) | 0.30 | 0.20 | 0.16 | 0.21 | 0.17 |
EPS (Diluted) | 0.30 | 0.20 | 0.16 | 0.21 | 0.17 |
EPS Growth | 50.09% | 24.21% | -23.89% | 27.33% | -1.54% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.54 | 0.42 | 0.96 | 1.3 | 0.86 |
Free Cash Flow Growth | 263.33% | -55.88% | -26.22% | 51.99% | 521.51% |
Free Cash Flow Per Share | 0.23 | 0.06 | 0.14 | 0.20 | 0.13 |
Dividends Per Share | - | 0.130 | 0.100 | 0.100 | 0.050 |
Dividend Growth | - | 30.00% | 0% | 100.00% | - |
Gross Margin | 69.05% | 65.93% | 65.32% | 68.96% | 71.72% |
Operating Margin | 31.59% | 26.07% | 21.39% | 30.18% | 27.09% |
Profit Margin | 32.81% | 25.38% | 21.74% | 26.66% | 24.10% |
FCF Margin | 25.17% | 8.04% | 19.39% | 24.53% | 18.57% |
EBITDA | 2.22 | 1.71 | 1.59 | 2.13 | 1.74 |
EBITDA Margin | 36.34% | 32.52% | 32.15% | 40.21% | 37.66% |
EBIT | 1.93 | 1.37 | 1.06 | 1.6 | 1.25 |
EBIT Margin | 31.59% | 26.07% | 21.39% | 30.18% | 27.09% |
Effective Tax Rate | -0.43% | 21.44% | 17.36% | 21.33% | 12.82% |